CCND1 and lymphoma: Overall, these insights underscore how a delicate balance of phosphorylation – and sumoylation-dependent degradation pathways is essential to prevent cyclin D1-driven tumorigenesis, and their dysregulation contributes to the development of lymphomas, providing potential targets for therapeutic intervention.